68Ga-PSMA PET/CT to Distinguish Brain Metastasis of Renal Cell Carcinoma From Radiation Necrosis After Stereotactic Radiosurgery

Filizoglu N., ALSAN ÇETİN İ., Kissa T. N., Niftaliyeva K., Ones T.

Clinical nuclear medicine, cilt.46, sa.11, ss.913-914, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 11
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1097/rlu.0000000000003820
  • Dergi Adı: Clinical nuclear medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.913-914
  • Anahtar Kelimeler: renal cell carcinoma, PSMA, PET/CT, brain metastasis, radiation necrosis
  • Marmara Üniversitesi Adresli: Evet

Özet

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.ABSTRACT: Renal cell carcinoma (RCC) is the most common primary malignancy of the kidney. Approximately 35% of patients of RCC presents with distant metastasis at initial evaluation. CT and MRI are the mainstay imaging modalities. Distinguishing radiation necrosis from tumor progression after stereotactic radiosurgery is challenging. Herein, we present a case of a 43-year-old man with RCC who was treated with stereotactic radiosurgery for brain metastases. We want to emphasize the potential value of 68Ga-PSMA PET/CT imaging in the differential diagnosis and follow-up of tumor progression from radiation necrosis in RCC patients.